Evidence map›Paper›PMID 38960564›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2024

How we treat type 2 low asthma.

Drew Harris, Larry Borish

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Drew HarrisDivision of Pulmonary Medicine, Department of Medicine, University of Virginia Health Systems, Charlottesville, Virginia.
Larry BorishDivision of Allergy, Asthma and Immunology, Department of Medicine, University of Virginia Health Systems, Charlottesville, Virginia. Electronic address: lb4m@virginia.edu.

Funding

Defining the Role of Immunoglobulin G4 (IgG4) in Food-Induced Eosinophilic Esophagitis (EoE)R01AI175232 · NIAID · UNIVERSITY OF VIRGINIA · PI Emily Clarke McGowan · 2023 to 2026
$3.1M
Protracted clinical and inflammatory response to rhinovirus challenge in human asthmaticsR56AI158519 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2022 to 2022
$323k
NIAID NIH HHS R01 AI175232NIAID NIH HHS R56 AI158519
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Asthmatic AgentsAsthmaHumansAnti-Asthmatic Agents

Identifiers

PMID38960564
PMCPMC11225797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.